Skip to main content

Home/ health information/ Group items tagged Advancements

Rss Feed Group items tagged

OAText's open access

Cancer journal - 0 views

Integrative Cancer Science and Therapeutics (ICST) is an open access, peer-reviewed online journal interested in attracting high-quality original research and reviews that present or highlight sign...

science icst journal

started by OAText's open access on 30 Mar 16 no follow-up yet
lifelinelab

Delhi Base Pathology Lab Near Me - 0 views

Lifeline laboratory are designed to identify the disease or illness of the humans on the basis of symptoms. Basically, humans get the physical test done in pathology labs on the behalf of doctors&...

Bestpathologylabs bestpathlabnearme Bestdiagnosticlab diagnosticcenternearme bestdiagnosticcenternearme diagnosticcenter bloodtestathome bloodtestathomenearme bloodonlinetest onlinebloodtest onlinebloodtestlabindelhi thyroidtestathome thyroidtestlabnearme

started by lifelinelab on 10 Oct 18 no follow-up yet
lifelinelab

Delhi Base Pathology Lab Near Me - 0 views

Lifeline laboratory are designed to identify the disease or illness of the humans on the basis of symptoms. Basically, humans get the physical test done in pathology labs on the behalf of doctors&...

Bestpathologylabs bestpathlabnearme Bestdiagnosticlab diagnosticcenternearme bestdiagnosticcenternearme diagnosticcenter bloodtestathome bloodtestathomenearme bloodonlinetest onlinebloodtest onlinebloodtestlabindelhi thyroidtestathome thyroidtestlabnearme

started by lifelinelab on 10 Oct 18 no follow-up yet
lifelinelab

BREAST CANCER SCREENING - 0 views

  What is screening ? Screening is looking for cancer before a person has any symptoms. This can help find cancer at an early stage. When abnormal tissue or cancer is found early, it may b...

Bestpathologylabs bestpathlabnearme Bestdiagnosticlab diagnosticcenternearme bestdiagnosticcenternearme diagnosticcenter bloodtestathome bloodtestathomenearme bloodonlinetest onlinebloodtest onlinebloodtestlabindelhi thyroidtestathome thyroidtestlabnearme

started by lifelinelab on 07 Dec 18 no follow-up yet
lifelinelab

THALASSEMIA SYNDROMES - 0 views

Thalassemias are a group of inherited blood dyscrasias that were first described in the Mediterranean region.In Greek”Thalassa” means sea and “haema “ means blood. Thalassem...

Bestpathologylabs bestpathlabnearme Bestdiagnosticlab diagnosticcenternearme bestdiagnosticcenternearme diagnosticcenter bloodtestathome bloodtestathomenearme bloodonlinetest onlinebloodtest onlinebloodtestlabindelhi thyroidtestathome thyroidtestlabnearme

started by lifelinelab on 20 Nov 18 no follow-up yet
chemtronbio2018

rapid test reader - 0 views

  •  
    We have two instruments: KD-I rapid test reader and KD-IV test reader. The both adopt the principle of reflectance spectrophotometer by using fiber-optical probe to collect reflected light and achieve the quantitative analysis of specimen. It is a portable, easy to use, rapid testing instrument designed to provide quantitative results for immunochromatographic lateral flow tests. This advanced point of care instrument delivers fast and accurate results in hospitals and laboratories. The quantitative tests are used for the test readers and can get a definitive result by the reader. It is easy to get a result by the test reader.
victormedic

wholesale surgical instruments - 1 views

  •  
    Victor Medical Instruments Co., Ltd is a professional firm of auto surgical staplers and Minimally Invasive Surgery related products, with full capability of products' developing, manufacturing and marketing. By providing surgeons with comprehensive surgical solutions, and offering our customers with advanced surgical devices, professional medical education, as well as superior customer service, Victor Medical has been constantly practicing the creed of being "professional, focused and concentrated."
pharmacybiz

OCTP's Cannabis-Derived Drug Reaches Phase 1 Milestone - 0 views

  •  
    Oxford Cannabinoid Technologies Holdings plc, which specialises in developing cannabis-derived medicines with pain-relieving properties, has successfully administered the first-in-human dose of its lead pharmaceutical drug compound, OCT461201, in its phase 1 clinical trial. The company holds a portfolio of four drug candidates intended for use as licensed pain medications. The drug is a selective cannabinoid receptor type 2 agonist with the potential to treat chemotherapy-induced peripheral neuropathy and irritable bowel syndrome. The UK trial, conducted by Simbec Research Limited, part of Simbec-Orion Group Ltd., is progressing with healthy volunteers, OCTP said in a statement. Using a single ascending dose protocol, the primary objective is to demonstrate OCT461201's safety and tolerability, while providing information on its pharmacokinetic profile, to confirm its value as a potential drug. Results from the trial, funded entirely by OCTP's existing resources, are expected in the third quarter of 2023, the statement added.
pharmacybiz

Transforming Community Pharmacy: NHS Commitments Unveiled - 0 views

  •  
    Since the introduction of the 2019 NHS Long-Term Plan, several policy commitments have surfaced, presenting a definitive 'blueprint' for community pharmacy in England. The Company Chemists Association has identified four crucial commitments that, when integrated, hold the potential to revolutionise patient care through community pharmacies. "Each commitment is like a crucial piece of a puzzle," CCA said. "For the transformation of patient access through community pharmacy to be successful, all these pieces must come together harmoniously. Otherwise, the picture will remain incomplete." The four major pieces of the puzzle coined by CCA include: * Building on education and training reforms to increase the size and capability of the workforce. * Expanding the number of clinical services commissioned and delivered in community pharmacy. * Introducing digital enablers which underpin service delivery. * Introducing legislative changes to increase capacity and allow the delivery of more patient-facing clinical care.
pharmacybiz

Pharmacy Quality Scheme 2022/23 begins from 10th October'22 - 0 views

  •  
    The Pharmaceutical Services Negotiating Committee (PSNC) has reminded community pharmacy contractors to start working on the quality criteria if they intend to meet the Respiratory domain of the Pharmacy Quality Scheme (PQS) 2022/23. For respiratory domain, community pharmacy contractors  must start working towards inhaler waste management; use of a spacer in patients aged 5-15 years; and personalised asthma action plans, from today (10 October). Resources are also available to support contractors with meeting the above criteria on the PQS hub page. PSNC also informed that contractors are also now able to make a claim for an Aspiration payment for the PQS 2022/23 on the NHS Business Services Authority (NHSBSA)  Manage Your Service (MYS) portal. "The Aspiration payment is optional; if contractors do not want to claim it, it will not impact on the contractor's ability to claim a PQS payment during the declaration period. There is also no requirement to have claimed for a previous PQS to claim an Aspiration payment for PQS 2022/23.
pharmacybiz

Andrew Stephenson:New Minister for Health and Secondary Care - 0 views

  •  
    Pendle MP Andrew Stephenson has been appointed as a Minister of State in the Department of Health and Social Care (DHSC) in the latest ministerial reshuffle. As the new 'Minister for Health and Secondary Care', Stephenson would be looking after elective care recovery and screening, as well as the fight against major diseases like cancer, diabetes and stroke, as reported by Burnley Express. "Helping NHS services recover from the legacy of the pandemic, whilst dealing with winter pressures and the challenges of inflation will not be easy, but it is a challenge I am looking forward to," Stephenson told Burnley Express. "I am also keen to ensure that significant manifesto commitments, such as the pledge to deliver 50,000 nurses and 40 new hospitals remain on track. Especially as one of those 40 new hospitals is Airedale, which is used by so many Colne and West Craven residents," he added.
pharmacybiz

Precision Medicine Launchpad Boosts NI's Life Sciences - 0 views

  •  
    The 'Life and Health Sciences Launchpad' has been introduced to focus on the precision medicine sector. It would help businesses and researchers to level up their impact on economic growth within the region. The launchpad has been funded by Innovate UK, part of UK Research and Innovation (UKRI). Kerry Curran, Director of GB & EU Trade in the Department for the Economy hailed the decision to support NI's "trailblazing" sector. She said: "Life and Health Science, including our highly innovative precision medicine cluster, is an area the Department is also prioritising through its 10X Economy Vision, and this Launchpad represents a further endorsement of the world-leading growth potential of precision medicine, and indeed life and health science, in Northern Ireland.
pharmacybiz

VIEWPOINT: It's already here - Latest Pharmacy News | Business | Magazine - Pharmacy Bu... - 0 views

  •  
    WAGMI or 'we are all gonna make it' is an established abbreviation in the crypto world, and pharmacists can learn from it. To all the dreamers, the visionaries, the go-getters, the futurists - we need you all. In the past few months, since the rebranding of Facebook into Meta, the word 'Metaverse' has become exponentially popular and there is a huge opportunity for pharmacists to get involved. In his popular podcast, Aragorn Meulendijks, the chief marketing officer at Your Open Metaverse - YOM, gave a crystal-clear vision on the unique and valuable possibility of a metaverse pharmacy or metapharmacy. Imagine it is 2030, and there are over a billion users of Virtual Reality headsets. You have recently been hired as the new metaverse pharmacist (metapharmacist) at the global metaverse pharmacy (metapharmacy) "YOMRx". Your patient comes to your metapharmacy with their digital twin (different to digital avatar)where you are able to provide them with medical advice (metaconsultation).
pharmacybiz

NHS-funded course on clinical skills : HEE - 0 views

  •  
    A new NHS-funded training course on clinical examination skills has been announced by Health Education England (HEE) for 10,000 community pharmacists. The training will be provided by CliniSkills and be coordinated by HEE with the Pharmacy Integration Programme at NHS England. With pre-registration now open to all community pharmacists, the programme will be available from 17th April 2023 and will until March 2024. It will be delivered online, with optional face-to-face attendance for pharmacists who would find this beneficial. Pharmacists will be required to complete a module on history taking and identification of serious conditions and can then choose from four optional modules, which cover the following themes: dermatology; cardiology; paediatrics; and ear, nose and throat. The training is designed to be complementary to the independent prescribing training and can be completed prior to or after an independent prescribing training course. It is open to all community pharmacists including those that work part time and locums.
pharmacybiz

Gene therapy to treat rare bleeding disorder - 0 views

  •  
    The European Union's health regulator on Friday said it had recommended granting a conditional marketing authorisation for a gene therapy by Australian drugmaker CSL Ltd and partner uniQure N.V. , to treat haemophilia B, a rare bleeding disorder which is caused by genetic anomalies. About one in 40,000 people are affected by the inherited disorder, caused by a gene mutation that hampers the body's ability to make clotting protein factor IX. If approved, the treatment, branded Hemgenix, will be the first gene therapy in the European Union for the condition that is usually treated by regular injections of factor IX, the European Medicines Agency said. CSL had acquired exclusive global rights to Hemgenix in May last year from uniQure N.V.
pharmacybiz

Meet Dr. Amira Guirguis RPS's New Science Committee Chair - 0 views

  •  
    The Royal Pharmaceutical Society (RPS) has appointed Dr Amira Guirguis as the new Chair of its Science and Research Committee, effective from the New Year. An accomplished pharmacist and renowned expert in substance misuse, Dr Guirguis was nominated by the RPS as a 'woman to watch' in 2020. Previously, she has served as the Principal Investigator for the first Home Office-licensed Pharmacist-led drug checking service in the UK, and as the MPharm Programme Director at Swansea University Medical School. A PhD in Novel Psychoactive Substances (NPS) detection, she has made significant contributions to the field of pharmacy, to drug policy, and has won the 2014 JPAG Geoffrey Phillips award for her groundbreaking research.
quangbang

Panorama Slim - A reputable weight loss support product - 2 views

Panorama Slim - A reputable weight loss support product Are you seeking a trustworthy and safe weight loss product? Let Panorama Slim accompany you on the journey to turn your dream of a slim figur...

panoramaslim panorama panoramagroup health pharmacy-business Treatment

started by quangbang on 11 Mar 24 no follow-up yet
robert1488stp

Sponsor & Exhibitor of Pediatric Neurology Summit - eMedEvents - 0 views

  •  
    This event provides an excellent opportunity for companies and organizations to showcase their products, services, and expertise to an engaged audience of pediatric neurologists and healthcare professionals.
pharmacybiz

3.7% Surge in Centenarians Revealed in ONS 2022 Report - 0 views

  •  
    The number of people living to be 100 or more increased by 3.7 per cent in England and Wales in 2022, compared to the previous year, according to new figures from the Office for National Statistics (ONS). ONS data also revealed that the number of centenarians in the UK has more than doubled in the last two decades. Wales has more centenarians (27 people per 100,000 aged 100 or over) than England (25 people per 100,000). It's good news that more people are living into their second century, but it also means that we may need to rethink our health plans for a longer future, a leading testing expert has suggested.
« First ‹ Previous 221 - 240 of 244 Next ›
Showing 20 items per page